Annual report pursuant to Section 13 and 15(d)

Receivable from Collaboration Partner

v3.21.2
Receivable from Collaboration Partner
12 Months Ended
Mar. 31, 2021
Warrant One [Member]  
Receivable from Collaboration Partner

This amount reflects a payment we made to a contract manufacturing organization for certain drug substance manufacturing services on behalf of our collaboration partner. Our collaboration partner reimbursed us for the payment in May 2021.